Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study ( REGESMOHS , Spanish registry of Mohs surgery)
Journal of the European Academy of Dermatology and Venereology · 2025-02 · 39 (2) · 426-434
DOI: 10.1111/jdv.20103 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 11.05.2024. Verfasst von Carlos Abril-Pérez und 40 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Mohs Surgery, Skin Neoplasms, Basal Cell Carcinoma, Immunocompromised Host. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Roche España.
Abstract (Originalsprache)
Background
Immunosuppressed (IS) patients, particularly solid organ transplant recipients and those on immunosuppressive therapy, face a higher incidence and recurrence of nonmelanoma skin cancers (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Mohs micrographic surgery (MMS) is the preferred treatment for high‐risk NMSC due to its high cure rate and margin examination capabilities. However, IS patients may experience more complications, such as surgical site infections, and a greater risk of recurrence, making their outcomes a subject of interest.
Objectives
This study aimed to compare IS and immunocompetent (IC) patients undergoing MMS for NMSC in terms of baseline characteristics, intra‐ and post‐surgical complications, and postoperative recurrence rates.
Methods
The study utilized data from the REGESMOHS registry, a 7‐year prospective cohort study in Spain. It included 5226 patients, categorizing them into IC (5069) and IS (157) groups. IS patients included solid organ transplant recipients, those on immunosuppressive treatments, individuals with haematological tumours and HIV‐positive patients. Patient data, tumour characteristics, surgical details and outcomes were collected and analysed.
Results
IS patients demonstrated a higher proportion of SCC, multiple synchronous tumours and tumours invading deeper structures. Complex closures, unfinished MMS and more surgical sections were observed in the IS group. Although intra‐operative morbidity was higher among IS patients, this difference became non‐significant when adjusted for other variables such as year of surgery, antiplatelet/anticoagulant treatment or type of closure. Importantly, IS patients had a substantially higher recurrence rate (IRR 2.79) compared to IC patients.
Conclusions
This study suggests that IS patients may be at a higher risk of development of AE such as bleeding or tumour necrosis and are at a higher risk of tumour recurrence. Close follow‐up and consideration of the specific characteristics of NMSC in IS patients are crucial. Further research with extended follow‐up is needed to better understand the long‐term outcomes for this patient group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hospital Universitario La Fe, Valencia, Spain.
- Instituto de Investigación Sanitaria La Fe (ISS La Fe), Valencia, Spain.
- Instituto Valenciano de Oncología, Valencia, Spain.
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Centro Médico Teknon, Barcelona, Spain.
- Complejo Asistencial Universitario de León, León, Spain.
ORCID-Profile: Carlos Abril-Pérez, Miguel Mansilla-Polo, Verónica Ruiz-Salas, Pedro Redondo, Pablo de la Cueva-Dobao, Raquel Navarro-Tejedor, Agustí Toll
Förderung
- Roche España
Zitieren
APA
Abril-Pérez, C., Mansilla-Polo, M., Escutia-Muñoz, B., Sanmartín, O., Garcés, J. R., Rodríguez-Prieto, M. A., Ruiz-Salas, V., de Eusebio-Murillo, E., Miñano-Medrano, R., González-Sixto, B., Artola-Igarza, J. L., Alfaro-Rubio, A., Redondo, P., Delgado-Jiménez, Y., Sánchez-Schmidt, J. M., Allende-Markixana, I., Alonso-Pacheco, M. L., García-Bracamonte, B., de la Cueva-Dobao, P., …, & REGESMOHS (Registro Español de Cirugía de Mohs) (2025). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study ( REGESMOHS , Spanish registry of Mohs surgery). Journal of the European Academy of Dermatology and Venereology, 39(2), 426-434. https://doi.org/10.1111/jdv.20103
Vancouver
Abril-Pérez C, Mansilla-Polo M, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, et al. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study ( REGESMOHS , Spanish registry of Mohs surgery). Journal of the European Academy of Dermatology and Venereology. 2025;39(2):426-434. doi:10.1111/jdv.20103
BibTeX
@article{AbrilPrez2025,
author = {Abril-Pérez, Carlos and Mansilla-Polo, Miguel and Escutia-Muñoz, Begoña and Sanmartín, Onofre and Garcés, Joan R and Rodríguez-Prieto, Manuel A and Ruiz-Salas, Verónica and de Eusebio-Murillo, Esther and Miñano-Medrano, Román and González-Sixto, Beatriz and Artola-Igarza, Juan L and Alfaro-Rubio, Alberto and Redondo, Pedro and Delgado-Jiménez, Yolanda and Sánchez-Schmidt, Julia M and Allende-Markixana, Irati and Alonso-Pacheco, María L and García-Bracamonte, Beatriz and de la Cueva-Dobao, Pablo and Navarro-Tejedor, Raquel and Ciudad-Blanco, Cristina and Carnero-González, Lucía and Vázquez-Veiga, Hugo and Cano-Martínez, Natividad and Serra-Guillén, Carlos and Vilarrasa, Eva and Sánchez-Sambucety, Pedro and López-Estebaranz, José L and Flórez-Menéndez, Ángeles and Martorell-Calatayud, Antonio and Gil, Pilar and Morales-Gordillo, Victoriano and Toll, Agustí and Ocerin-Guerra, Izascun and Mayor-Arenal, Matías and Suárez-Fernández, Ricardo and Sainz-Gaspar, Laura and Descalzo, Miguel A and Garcia-Doval, Ignacio and Botella-Estrada, Rafael and REGESMOHS (Registro Español de Cirugía de Mohs), REGESMOHS (Registro Español de Cirugía de Mohs)},
title = {Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study ( REGESMOHS , Spanish registry of Mohs surgery)},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {2},
pages = {426--434},
doi = {10.1111/jdv.20103}
}
EUVIMED